| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000025331 |
| Receipt No. | R000029140 |
| Official scientific title of the study | Research on the effect of a proton pump inhibitor on the oral and intestinal microbiota and salivary protein and metabolites. |
| Date of disclosure of the study information | 2016/12/20 |
| Last modified on | 2016/12/20 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Research on the effect of a proton pump inhibitor on the oral and intestinal microbiota and salivary protein and metabolites. | |
| Title of the study (Brief title) | Influence of PPI on oral microbiota | |
| Region |
|
|
| Condition | ||
| Condition | healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of the present study was to explore the influence of PPI usage on the oral and gut microbiota with healthy volunteers. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Ten adult healthy volunteers with no medications donated the fecal, saliva and periodontal pocket fluid samples before and after administration of esomeprazole 20mg once daily for 4 weeks. We then investigate the effect of PPIs on the bacterial communities using 16S rRNA gene sequencing method. |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) over 20 year old
2) Informed consent about this research has been obtained with participants in writing form. |
|||
| Key exclusion criteria | 1) daily usage of steroids, immunosuppresive and anticancer drugs
2) 20 or fewer teeth 3) using antibiotics during use or within 1 month 4) During pregnancy, lactating, a woman who may be pregnant 5) history of allergy to esomeprazole 6) A case of a history of resection of the gastrointestinal tract except for appendectomy 7) the research director judged inappropriate as the subject of this research |
|||
| Target sample size | 24 | |||
| Research contact person | |
| Name of lead principal investigator | Tsuyoshi Mishiro |
| Organization | Shimane university school of medicine |
| Division name | Division of gastroenterology |
| Address | 89-1 Enya-cho, Izumo, Shimane, Japan |
| TEL | 0853-20-2190 |
| tmishiro@med.shimane-u.ac.jp | |
| Public contact | |
| Name of contact person | Tsuyoshi Mishiro |
| Organization | Shimane university school of medicine |
| Division name | Division of gastroenterology |
| Address | 89-1 Enya-cho, Izumo, Shimane, Japan |
| TEL | 0853-20-2190 |
| Homepage URL | |
| tmishiro@med.shimane-u.ac.jp | |
| Sponsor | |
| Institute | Shimane university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Ten adult healthy volunteers with no medications donated the fecal, saliva and periodontal pocket fluid samples before and after administration of esomeprazole 20mg once daily for 4 weeks. We then investigate the effect of PPIs on the bacterial communities using 16S rRNA gene sequencing method. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029140 |